This inventor holds 1 USPTO granted patent. Top assignees: Taisho Pharmaceutical Co., Ltd., Teijin Limited, Other. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 314 
1 out of 1,605 
1 out of 834,570 Years Active: 1997
Title: Shigeru Nakayana: Innovator in Pharmaceutical Composition
Introduction
Shigeru Nakayana is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the therapy of cerebral thrombosis. His innovative work has led to the development of a unique pharmaceutical composition that addresses this critical health issue.
Latest Patents
Shigeru Nakayana holds 1 patent for his invention titled "Pharmaceutical composition for the therapy of cerebral thrombosis." This patent reflects his dedication to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Nakayana has worked with prominent companies in the pharmaceutical industry. He has been associated with Taisho Pharmaceutical Co., Ltd. and Teijin Limited, where he has contributed his expertise in drug development and innovation.
Collaborations
Shigeru Nakayana has collaborated with esteemed colleagues, including Kiyoshi Bannai and Yutaka Mizushima. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Shigeru Nakayana's contributions to the field of pharmaceuticals, particularly through his patent for a cerebral thrombosis therapy, highlight his role as an innovator. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile